|
|
|
ComplianceOnline, Online Event
2012-07-11
Why Should You Attend: Many companies struggle with understanding what FDA, MHRA, EU and other Ministries of Health want to see regarding software validation.This presentation will review the FDA validation process, the GAMP® software validation model, and the process defined in GAMP® 5 as it applies to FDA software validation. The attendee should leave the presentation confident in their ability to understand and apply the GAMP® 5 process. - FDA inspectors are now being trained to evaluate software validation practices.
- Increasing use of automated manufacturing and quality systems means increased exposure
- Most recalls can be traced back to computerized equipment, exposing the validation process to scrutiny
- Corporate uncertainty leads to inaction and 'wheel spinning'
- A third of recent warning letters included citations with respect to improper or ineffective validation
Areas Covered in the seminar: - Outline of FDA regulations as applied to software.
- Review of FDA software validation requirements.
- Why validation makes good business sense.
- Strategies on how to avoid the most common problems.
- The GAMP® approach.
- Advice on successful validation project staffing.
- GAMP® 5 Principles.
- GAMP® 5 as applied to FDDA software validation.
- Using GAMP® 5 to cut validation costs.
|
|
|
|
|
|
Organized by:
|
|
ComplianceOnline |
|
Invited Speakers:
|
|
Alfonso Fuller, is the founder and President of Fuller Compliance, a consulting firm that specializes in FDA quality system, software quality and software validation for pharmaceutical, biotech and medical device companies. Al is the author of several white papers, has spoken at numerous seminars, and has represented many clients before FDA compliance and enforcement personnel, and actively consults on day-to-day compliance issues
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2012-07-11
|
|
|
|
|
|
Registration:
|
|
For Registration:
|
|
E-mail:
|
|
referral@complianceonline.com
|
|
|
|
|
|
|
|